IRIS

Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 60
Titolo Tipologia Data di pubblicazione Autore(i) File
Development of a Patient-Reported Outcome Measure (PROM) for Dysgeusia During Treatment With Smoothened (SMO) Inhibitors for Basal Cell Carcinomas: The SMO-iD Questionnaire 1.1 Articolo in rivista 2023 Camela, Elisa; Villani, Alessia; Ocampo Garza, Sonia Sofia; Costa, Claudia; Fabbrocini, Gabriella; Megna, Matteo; Potestio, Luca; Ruggiero, Angelo; Scalvenzi, Massimiliano
The effectiveness of vismodegib in patients with advanced periocular basal cell carcinoma: a case series of 13 patients 1.1 Articolo in rivista 2022 Villani, A; Costa, C; Cappello, M; Fabbrocini, G; Scalvenzi, M
Assessment of the adverse events related to hedgehog pathway inhibitor therapy for basal cell carcinoma: A single-centre retrospective study 1.1 Articolo in rivista 2021 Villani, A.; Fabbrocini, G.; Costa, C.; Cappello, M.; Scalvenzi, M.
Dose reduction during routine treatment of locally advanced basal cell carcinoma with the hedgehog inhibitor sonidegib to manage adverse effects: A retrospective case series 1.1 Articolo in rivista 2021 Villani, Alessia; Costa, Claudia; Fabbrocini, Gabriella; Ruggiero, Angelo; Scalvenzi, Massimiliano
Awareness on sun protection behavior among melanoma and nonmelanoma skin cancer patients: An Italian tertiary cancer center experience 1.1 Articolo in rivista 2021 Villani, A.; Fabbrocini, G.; Costa, C.; Scalvenzi, M.
Response to "Efficacy of sonidegib in histologic subtypes of advanced basal cell carcinoma: Results from the final analysis of the randomized phase 2 Basal Cell Carcinoma Outcomes with LDE225 Treatment (BOLT) trial at 42 months" 1.1 Articolo in rivista 2021 Villani, Alessia; Fabbrocini, Gabriella; Costa, Claudia; Scalvenzi, Massimiliano
BRIT‐1 expression and its relationship with PARP‐1 and CAF‐1/p60 in cutaneous melanoma 1.1 Articolo in rivista 2021 Russo, Daniela; Travaglino, Antonio; Varricchio, Silvia; Merolla, Francesco; Ilardi, Gennaro; Raffone, Antonio; Scalvenzi, Massimiliano; Costa, Claudia; Fabbrocini, Gabriella; Staibano, Stefania; Mascolo, Massimo
Tissue Expression of Carbonic Anhydrase IX Correlates to More Aggressive Phenotype of Basal Cell Carcinoma 1.1 Articolo in rivista 2021 Russo, Daniela; Varricchio, Silvia; Ilardi, Gennaro; Martino, Francesco; Di Crescenzo, Rosa Maria; Pignatiello, Sara; Scalvenzi, Massimiliano; Costa, Claudia; Mascolo, Massimo; Merolla, Francesco; Staibano, Stefania
A rare evolution of porokeratosis 1.1 Articolo in rivista 2020 Mascolo, Massimo; Patrì, Angela; Pace, Mirella; Costa, Claudia; Varricchio, Silvia; Travaglino, Antonio; Scalvenzi, Massimiliano
Second primary melanoma: incidence rate and risk factors 1.1 Articolo in rivista 2020 Villani, A.; Fabbrocini, G.; Costa, C.; Greco, V.; Scalvenzi, M.
Leiomyoma of the finger in a patient affected by cutaneous Kaposi's sarcoma 1.1 Articolo in rivista 2020 Scalvenzi, Massimiliano; Costa, Claudia; Villani, Alessia; Cappello, Milena; Mascolo, Massimo; Pagliuca, Francesca; Fabbrocini, Gabriella; De Fata Salvatores, Gaia
Trends in epidemiology of melanoma in situ in a center of South-Italy: Data from a melanoma reference center during the period 2004–2018 1.1 Articolo in rivista 2020 Villani, A.; Costa, C.; Fabbrocini, G.; Cinelli, E.; Greco, V.; Scalvenzi, M.
Advanced basal cell carcinoma treated with vismodegib: impact on the lives of patients and their families 1.1 Articolo in rivista 2020 Villani, A; Cappello, M; Costa, C; Fabbrocini, G; Scalvenzi, M
Cutaneous melanoma associated with naevi prevalence: A 15-year cross-sectional retrospective study 1.1 Articolo in rivista 2020 Scalvenzi, Massimiliano; Megna, Matteo; Costa, Claudia; Fabbrocini, Gabriella; Villani, Alessia; Greco, Vincenzo
Melanoma Screening Days During the Coronavirus Disease 2019 (COVID-19) Pandemic: Strategies to Adopt 1.1 Articolo in rivista 2020 Villani, A.; Fabbrocini, G.; Costa, C.; Scalvenzi, M.
Reply to Wong C et al. "Comparison of daily dosing vs. Monday through Friday dosing of vismodegib for locally advanced basal cell carcinoma (laBCC) and basal cell nevus syndrome: a retrospective case series" 1.7 Commento, erratum, replica e simili 2020 Villani, Alessia; Costa, Claudia; Fabbrocini, Gabriella; Cappello, Milena; Scalvenzi, Massimiliano
A case of Paediatric Acrodermatitis Continua of Hallopeau successfully treated with adalimumab biosimilar 1.1 Articolo in rivista 2020 Megna, Matteo; Fabbrocini, Gabriella; Costa, Claudia; Ferrillo, Maria
Lichenoid rash: A new side effect of oral Cladribine 1.1 Articolo in rivista 2020 Aruta, F.; Iovino, A.; Costa, C.; Manganelli, F.; Iodice, R.
Drug holiday regimen for vismodegib treatment in patients with multiple primary basal cell carcinomas 1.1 Articolo in rivista 2020 Villani, A.; Costa, C.; Fabbrocini, G.; Scalvenzi, M.
Sonidegib: Safety and Efficacy in Treatment of Advanced Basal Cell Carcinoma 1.1 Articolo in rivista 2020 Villani, A.; Fabbrocini, G.; Costa, C.; Scalvenzi, M.
Mostrati risultati da 1 a 20 di 60
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile